­º­¶³Ì·s®ø®§Â²¤¶¨C¤éÆF­×¹q¤l¶P¥d«H®§¤À¨Éºô¤W¸ê·½Ápµ¸§Ú­ÌEnglish
¸t¸gª÷¥y

­C©MµØ¬O¨}µ½¥¿ª½ªº¡A©Ò¥H¥L¥²«ü¥Ü¸o¤H¨«¥¿¸ô¡C
¸Ö½g25¡G8


新版聖經工具
 
ªñ´Á¬¡°Ê»P·P®¦°O¨Æ
ºô¤W¤U¸ü-¹q¤l®Ñ¡B¼v­µ¤å¥ó
ºô¤WÀy§Ó°Êµe¤U¸ü
»´ÃP¥Í¬¡ªº°Êµe¤U¸ü
W4J ¥\¯à¤¶²Ð
W4J¦¬¶O¼Ð·Ç
W4JÀ³¥Î¹ê¨Ò
¸t¸g¬d¸ß
2006網路事工研討會
­µ¼Ö¸ÖºqÂI¼½
¥Ø¿ý¾ÉÄý
³Ì·s®ø®§
²§¶H¡B¨Ï©R¡B»P¥Në
±Ð·|¦h´CÅé§Þ³N¤À¨É
«Å±Ð¤â°O
W4J µo®iª¬ªp
µu¤å¤À¨É
¥Nëºô
¯îºz¥Ì¬u
W4J¨£ÃÒ¹ê¨Ò
W4J¹q¤l³ø
±Ð·|¾÷ºc±MÄæºë¿ï
¦P¤uÁpµ¸Ã¯
ºô¤W¥I¶O
¬G»Ù¥Ó§i
Ápµ¸§Ú­Ì
ºô¯¸ºûÅ@

³]¬°­º­¶
¥[¤J¡u§Úªº³Ì·R¡v
ÂsÄý¬y¶q²Î­p
¤H¼Æ: 12,819,673 
­¶¼Æ: 59,626,691 
¤U¸ü: 28,841 
Since May 2004

­q¾\¹q¤l³ø

­q¾\¹q¤l¶g³ø
¦Û­q¾\¦W³æ²¾°£
¹q¶lEmail:



  
   

Bookmark and Share   
 
¦Û³¬¯g¨àµ£ºÎ¯v°ÝÃDªº¬ã¨s±M®×©M¨ó§U«Øij

½@¤ß
4/2/2018



¦Û³¬¯g¨àµ£ºÎ¯v°ÝÃDªº¬ã¨s±M®×©M¨ó§U«Øij
§@ªÌ¡G½@¤ß

¬ü°ê°ê®a½Ã¥Í°|(National Institute of Health, NIH)Äw³]¤½¦@Âå¾Ç¸ê°T¤¤¤ß(PubMed Central, PMC) ¡A2018¦~¤@¶µ³Ì·sªº¦Û³¬¯g¨àµ£ºÎ¯v»Ùꪺ¬ã¨s±M®×µoªí, ¬O¥Ñ­^°êªºµÜ´µ¯S¤j¾Ç©M§B©ú¿«¤j¾Çªº¬ã¨s¤H­û°w¹ï¦~ÄÖ¦b2-15 ·³ªº¨àµ£¡A±´°Q¤F¬°¤°»ò¦³¯«¸gµo¨|»Ùꪺ¨àµ£·|¦³§ó°ª¤ô¥­ªººÎ¯v¤¤Â_, ¨ä¤¤¥]¬A¦Û³¬¯g(ASD)¡B¥v±K´µ-°¨¦N§Qºî¦X¯g (Smith-Magenis Syndrome)¡Bµ²¸`©Êµw¤Æ¯g(tuberous sclerosis complex) ©M¤Ñ¨Ï¤H¯g­Ô¸s (Angelman Syndrome)¡C¦b³o¶µ¬ã¨s¤¤, ¤@¥÷¼Ð·Ç¤Æªº°Ý¨÷¬O¸ó²Õ¶i¦æªº, ¥H¤ñ¸ûºÎ¯v¯¿¶Ãªº´¶¹M©M·§ªp, ¨Ã»P¦~Ä֤ǰtªº¨å«¬µo®i (TD) ¦PÄÖ¤H¹ï¤ñ¡C³o¨Ç«Ä¤l¤¤¦³30¦ì¯«¸gµo¨|»Ùê¨àµ£¬O³Q¶EÂ_¬°¦Û³¬¯g(ASD) ¡A¥t¦³47¦ì¥¿±`¨àµ£¬O¹ï·Ó¤p²Õ¡C

ºI¨ú©Î¨Ï¥Î¦¹½g¤¤¤å¤º®e¡BÂഫ²Å餤¤å¡A½Ðµù©ú¥X³B www.autismawakening.org ¤Î§@ªÌ½@¤ß¡C

¦Û³¬¯gºÎ¯v¬ã¨s³zÅS¤F¤°»ò¡H
¥»¬ã¨s±Ä¥Î§ï¨}ªºSimonds and ParragaºÎ¯v°Ý¨÷ (Modified Simonds and Parraga¡¦s sleep questionnaire), ¥H¿ë»{¦UºØ¯«¸gµo¨|»ÙꪺºÎ¯v»Ùê¯S¼x, ¨Ã±´¨D¨Ï±Ó·P©Êªººî¦X¯g±o¨ìªvÀøªº¤èªk¡C¬ã¨s¤H­ûµo²{, ©M¥¿±`¦PÄÖ¤H¤ñ¸û¡A30%ªº¦Û³¬¯g¨àµ£¦³§xÃø¦wí½ö¤U¹w³ÆºÎı, ¦³43% ªº¦Û³¬¯g¨àµ£§ó¬O±Ã¤ã¤_«O«ù¼ôºÎªº°·±d³W«ß¡C»P¨ä¥L¯«¸gµo¨|»Ùꪺ¨àµ£¤ñ¸û¡A¤£¦Pªº¬O, ¦Û³¬¯g(ASD) ¨àµ£ªº©]¶¡¹Ú¹C©M²M±á¥E¿ôªº±¡ªp¸û¤Ö¡F¦ý»P¨å«¬¥¿±`ªº¦PÄÖ¤H¤ñ¸û, ¦Û³¬¯g(ASD) ¨àµ£©]¶¡¹Ú¹C©M²M±á¥E¿ôªº±¡ªp¸û°ª¡CµM¦Ó©Ò¦³¨ã¯«¸gµo¨|»Ùê¨àµ£ªº¬ã¨s¼Æ¾ÚÅã¥Ü¡A¬O¤ñ¨å«¬¥¿±`ªº¦PÄÖ¤H¦³§ó°ªªº©]¶¡¹Ú¹C, ¥Õ¤Ñ¶ÝºÎ, ´c¹Ú©M©]Å媺±¡ªp¡C ¥t¥~ªº¯gª¬, ÁÙ¥]¬A­G­¹¹D°f¬y, ¹L°Ê, ©M·¥®tªº±±¨î±¡ºü½Ä°Ê¡A¤]³Qµo²{¬O¤Þ°_ÄY­«ºÎ¯v¤¤Â_ªºÅܼơC³o¨Ç±¡ªp³y¦¨ªººÎ¯v¤¤Â_¡A·¥®e©ö¾É­P¦Û³¬¯g(ASD)¨àµ£ÀWÁc¦aªí²{·Ðļ©ö«ãªº°ÝÃD¦æ¬°¡A¤]¦P®É¼W¥[¤F¥D­n·ÓÅUªÌªº¯h³Ò¡C (Trickett, Heald, Oliver, & Richards, 2018)

¦p¦ó¨Ï§Úªº¦Û³¬¯g«Ä¤l¤JºÎ¡H
ºÎ¯v°ÝÃD¦b«Ä¤l·í¤¤¬O«Ü±`¨£¡C¦ý¹ï©ó¦Û³¬¯g¨àµ£¨Ó»¡, ºÎ¯v¥i¯à¬O§ó¨ã¬D¾Ô©Ê¡C«ùÄòªº¬ã¨s¤@¦Aµý©ú,
¦h¹F80% ªº¦Û³¬¯g¨àµ£¦³¬YºØµ{«×ªººÎ¯v§xÃø¡C³Ì±`¨£ªº­ì¦]¬OÃø¥H¤JºÎ©M/©Î«O«ù¼ôºÎªº§xÃø¡C


Ãö¤_ºÎ¯vªº°Q½×¡A­º¥ýÀ³¸Óª`·N°ò¥»ªº°ÝÃD-¨}¦nªººÎ¯v½Ã¥Í¡CºÎ¯v½Ã¥Í¨ì©³¬O¤°»ò¡H²³æ¦a»¡, ºÎ¯v½Ã¥Í¬O§Ú­Ìªº¦æ¬°©M§Ú­Ì©P³òªº¨Æ±¡, ¬O¨¬¥HÀ°§U©Î¬O¶Ë®`§Ú­ÌºÎ¯v«~½èªº²Õ¦X¡C¥H¤U¥|­Ó²Õ¦¨³¡¤À, ¹ï¨}¦nªººÎ¯v½Ã¥Í¦ÜÃö­«­n: ¨Ò¦æ, ®Éµ{ªí, Àô¹Ò, ¥H¤ÎÁקK©MªvÀøºÎ¯v¤zÂZ¡C

1¡V ¤£ÅܪººÎı±`³W:

¨C­Ó«Ä¤l³£À³¸Ó¦³¤@®M©]¶¡ªº§@®§³W«ß¡CºÎ¯v²ßºD¥]¬A¤@¨t¦Cªº¬¡°Ê, ¨C±ßÀ³¦b¦P¤@®É¶¡¥H¦P¼Ëªº¤è¦¡¹w³Æ´N¹ì¡C³o¨Ç¬¡°ÊÀ³¸Ó¯àÅý§Aªº«Ä¤l³vº¥©ñÃP¡B¥¢¥h°Ê¤O¡C¦Û³¬¯g(ASD)¨àµ£ªº¯S½è§óÀ³¬O¶É¦V¤_©T¦u±`³W, ©Ò¥H¤@¥¹«Ø¥ß¤F©]¶¡ªº¨Ò¦æµ{¦¡, ·Ó²z¬O¯à«Ü®e©ö¦aÄ~Äòºû«ù¤U¥h¡C¦b¦¹¡A§Ú«Øij¥®Ä֩ΧC¤f»yªº¦Û³¬¨à(ASD)®aªø­Ì·Ç³Æ¤@­Ó©]¶¡¨Ò¦æªºµøı¹Ï¨Òªí, ¥HÀ°§U«Ä¤l¾Ç²ß»{ÃÑ­Ó§O¦æ°Êªº²Õ¦¨©M¶¶§Ç¡C

¤@¥¹¹B¥Îµøı¤Æ¹Ïªí¥H DTT(FIFO or LIFO) ªº°V½m¨Ï¤@­Ó³¡¤Àªº¦æ¬°²ß±o«á,¦A¦¸Åã¥Üµøı¤Æ¹Ïªí¥H«ü¥Ü¤U¤@­Ó¶¶§ÇÀ³¬O­þ­Ó¨BÆJ¡Cµøı¤Æ¹Ïªíªº³Ì«á¤@¨BÀ³¸Ó¬O«Ä¤l½ö¦b§É¤W©M¤÷¥À»¡±ß¦w¡C¤¤¶¡ªº¬¡°ÊÀ³¸Ó¬O¦wÀRªº, ÁקKÅý«Ä¤l¼ÉÅS¦büL¯P¥ú½u¤U¡B
ÁקK¬D°_ºë¯«ªº¿³¾Ä(¨Ò¦p·kÄo)¡B¥H¤ÎÁקK¨­Å鱵IJ¤Wªº¨ë¿E(¨Ò¦p«ö¼¯)¡C¤@­Ó¦nªº¨Ò¦æµ{¦¡À³¸Ó¦³20¨ì30¤ÀÄÁªºªø«×¡C¦b³o¬q®É¶¡¸Ì, ÁקK¨Ï¥Î¹qµø¡B¥­ªO¹q¸£©M´¼¼z¤â¾÷¬O«D±`­«­nªº¡C©Î³\¦³¨Ç«Ä¤l¨Ï¥Î³o¨Ç¤u¨ã¥i¥HÀ°§U¦Û¤v¥­ÀR¤U¨Ó, ·Ç³ÆºÎı¡C¦ý§Ú¨ÌµM¹ªÀy®aªø¦b±ß¤W¦­¨Ç²¾¨«³o¨Ç¹q¤lÃþ«¬ªº¬¡°Ê, ¥HÁקK¦bºÎı«e¦Ü¤Ö¤@¤p®É±q¤¤±o¨ì3C¿Ã¹õÂÅ¥ú¹ïµøıªº¹L«×¨ë¿E¡Cµøı¼ÉÅS©ó3C¿Ã¹õÂÅ¥úªº®É¶¡ªø«×¡B¶ZÂ÷©M±j«×¡A¬ì¬ãµý¾ÚÅã¥Ü¬O¥i¥H§ïÅܤj¸£¿Æ¶Â¯À¤Àªc(melatonin secretion)ªº¼Ò¦¡, ³o¬O¤@ºØ­«­nªººÎ¯v²üº¸»X¡C¹ï©ó¦Û³¬¯g¨àµ£¦Ó¨¥, ªñ¤W¤dªº¬ã¨s»¡©ú, ¥L­Ìªº¿Æ¶Â¿E¯À¤Àªc¬O®e©ö¥X²{¥\¯à»Ùꪺ°ò½u¡CºÎ«eªºÃn¤_ÂÅ¥ú¤U·|¨Ï±¡ªp§óÁV¡C

2- ¾A·íªººÎ¯v®Éµ{ªí:

«Ä¤l»Ý­n¦h¤Ö¤p®ÉªººÎ¯v¡H«Ä¤lÀ³¸Ó¦³¦h¤[ªº¤Èı¡H«Ü©úÅã, ³\¦h¦Û³¬¯g¨àµ£¦ü¥G¨Ã¤£¹³¨ä¥L¦PÄ֫Ĥl¤@¼ËªººÎ¯v¼Ò¦¡, ¥L­Ì¤]¤£¦]¦¹¦³§ó¦hªº¤p¤ÈºÎ, ¦ý¥Õ¤Ñ¦ü¥G¤£¯h­Â¥i¥H«O«ù²M¿ô¡C¬°¤F¯à²Ê²¤¦aÁA¸Ñ§Aªº«Ä¤l»Ý­n¦h¤ÖºÎ¯v, ¤U­±¬O¤@±i¤j¦h¼Æ¥¿±`µo®iªº«Ä¤l©Ò¨Ï¥Îªº¹Ïªí¡C½Ð°O¦í, ¦Û³¬¯g¨àµ£¥i¯à¬O§¹¥þ¤£¾A©ó³o­Ó½d³ò, ¦ý³o­Ó¹Ïªí¸ê®Æ¶È§Æ±æµ¹§A¤@­Ó°Ñ¦ÒÂI¡C

¦~ÄÖ¥­§¡    »Ý­nªººÎ¯v®É¶¡    ¤ÈºÎ¦¸¼Æ
0¡V3 ­Ó¤ë      12¡V18¤p®É              3+
3¡V12­Ó¤ë     14¡V15¤p®É              2-4
1¡V3·³           12¡V14¤p®É              1-2
3¡V5·³           11¡V13¤p®É               0-1
5¡V10·³         10¡V12¤p®É               0
10¡V17·³        8.5¡V10¤p®É             0
¦¨¦~              7¡V9¤p®É                  0

Source: §Úªº«Ä¤l¤£ªÖºÎı(My Child Won¡¦t Sleep) Kansagra S, Createspace Publishers, South Carolina: 2014. ³o­Ó¹Ïªí¸ê°T¬O«ùÄòºÎ¯v®É¶¡ªº¤@­Ó¥¿±`½d³ò, ¦ý¨C­Ó«Ä¤l³£¬O¤£¦Pªº¡C

3- ¤@­ÓµÎ¾AªºÀô¹Ò:

³o¬OÅã¦Ó©ö¨£ªº, ºÎ¯vÀô¹ÒÀ³¸Ó¬O¤@­Ó¦³¦X©yªº·Å«×, ¨Ã¥B¨S¦³¹L¦hªº¾¸­µ¡C¤@¯ëºÎ¯v®ÉÅé·Å·|¤U­°, «Ç内¤Ó¼ö·|§í¨î¤JºÎªº¯à¤O¡C¦]¦¹, §Ú³q±`«ØijºÎ©Ð¦b¸û²Dªº¤@°¼, ¦A¬ï·x¨Ç¤JºÎ¡CµM¦Ó, ¦Û³¬¯g¨àµ£¦]¬°¦³¤@©wªº·P©x°¾¦n, Ä´¦p³ßÅw§ó¦h(­«)ªº´à¤l©Î¬Y¨Ç½è§÷/Ãþ«¬ªº¦çªA¡C³Ì­«­nªº, ¬O¥Hº¡¨¬«Ä¤l·P¨ìµÎªA¡C¦³¤@¨Ç®aªøµo²{, ¨Ï¥Î¥[­«¤ò´à¯à¨Ï¦Û³¬¯g¨àµ£¦¨¥\¤JºÎ¡A´£¨Ñ«Ä¤lÃB¥~ªº¦w¥þ·P©M·P©x¨ë¿E¡C¦b¦¹½Ð°O¦í, ³Ì·sªº¤@¶µ¬ì¾Ç±´°Q¬ã¨s¡A«oµo²{¥[­«ªº´à¤l¨S¦³Åã¥Ü¥X¥i¥H§ïµ½¦Û³¬¯g¨àµ£ªººÎ¯v, ¦ý¦³¨Ç¦Û³¬¯g©M¤÷¥À¦ü¥G¤´µM³ßÅw¨Ï¥Î¥[­«¤ò´à¡C¦pªG§Aı±o§Aªº«Ä¤l·|¦]¦¹¨ü¯q, ¨º´N¤@¸Õ§a¡C

4- ºÎ¯v¤zÂZªºÁקK©MªvÀø¡G

¤@­Ó¥D­n¤zÂZºÎ¯vªº¦]¼Æ¬O©@°Ø¦]¡C§Y¨Ï¬O¦b¦­±á¥H©@°Ø¡B¯ù¡B¨T¤ô©Î¥©§J¤Oªº§Î¦¡©Ò³Ü¤Uªº©@°Ø¦]¤]·|ÂZ¶Ã©]¶¡ªººÎ¯v¡C¤@¯ë¨Ó»¡, ¤£ºÞ¬O§_¦³ºÎ¯v°ÝÃD¡A§Ú«Øij«Ä¤l­Ì¤£­n¦Y¥ô¦ó§t¦³©@°Ø¦]ªº²£«~¡C¦P¼Ë¡A¥Í²z¤WªºÂåÀø°ÝÃD¤]·|ÂZ¶ÃºÎ¯v, ¥]¬A¦]¹L±Ó¤Þ°_ªº»ó¶ë¡BÀã¯l¡BºÎ¯v²¿®§¯g¡B¤£¹ç»Lºî¦X¯g©M­G­¹¹D°f¬y(¤ßµh)¡C³o¨ÇÀ³¸Ó­n¨D¨à¬ìÂå¥Í¥J²ÓÀËÅç¨Ã³B²z¡C

¤@¥¹®a®x«Ø¥ß¤F¨}¦nªººÎ¯v½Ã¥Íªº°ò¦±ø¥ó, ¤÷¥À´N¤w¸g·Ç³Æ¦n¶i¦æ¤¶¤J¤@¨Ç­«ÂIªº¦æ¬°ªvÀøªº¨ãÅé°ÝÃD¡C

­º¥ý¡A¡§¨S¦³§Ú¦b¨­®Ç³­ºÎ¡A§Úªº«Ä¤l¤£·|¤JºÎ¡C¡¨

³q±`¦³¨â­Ó¥D­n­ì¦], ¨àµ£¤@©w­n¤÷¥À¦P¦b¤~ªÖºÎ¡C²Ä¤@ºØ¬OµJ¼{, ³o¦b¦Û³¬¯g¨àµ£¤¤¬O¬Û·í¬ðÅ㪺ª¬ªp¡A¦]¬°¥Í¬¡¤¤¬O§¹¥þ¨Ì¿à¤÷¥À¤~¯à满¨¬©Ò±ý¡A¤÷¥ÀÀ³¸Ó¥i¥HÆ[¹î¨ì«Ä¤l©]±ß¦bµJ¼{°ò¦¤Wªº­«ÂЩʦ欰¡C¦pªG§Aªº«Ä¤l¹L©óµJ¼{, ½Ð­n¨D±M·~ªº¤ß´¼¨à¬ìÂå¥Í¶i¦æµû¦ô¡F¹ï©óµJ¼{ªº«Ä¤l¦Ó¨¥, ¿W¥ß¤JºÎªº°V½m´Á¶¡¡AºÎ«eªº¹L´ç¬¡°ÊÀ³¸Ó¬O½wºC¦Óí©wªº¡C§Ú³q±`«Øij¦b¨Ò¦æ¬¡°Ê¤§«á¡A¤÷¥À¹w³Æ«Ä¤l½ö¦b§É¤W, µM«á§b¦b©Ð¶¡¸Ì§¤¦b§ÉÃ䪺´È¤lª½¨ì«Ä¤lºÎµÛ¡CÀHµÛ®É¶¡(¤@­Ó¬P´Á)ªº±À²¾, ¤÷¥À­ÌÀ³¸Ó³­«Ä¤l¤JºÎªº®É¶¡¤£ÅÜ¡A¦ý¨­Åé¶ZÂ÷¬O¶i¤@¨B¦V©Ðªù²¾°Ê, ¦]¬°¥D­nªº¥Ø¼Ð¬O´î¤Ö©]¶¡ªºµJ¼{, ¨Ã¹ªÀy«Ä¤l¿W¥ß¤JºÎ¡C

²Ä¤G­Ó­ì¦], «Ä¤l»Ý­n¤÷¥À³­µÛ¤JºÎ¬O¥Ñ©óºÎ¯vªº»{ª¾Ápµ²(Sleep Associates)¡C¨Ò¦p, ¤@­Ó¥¿±`¨àµ£ºÎ¯vªº»{ª¾Ápµ²±`¨£¬O没¦³¼ô±xªº©êªE©Î¬v«½«½, ´N«ÜÃø¤JºÎ¡C¦P¼Ë, ¤@­Ó±q¤pÁ`¬O©M¶ý¶ý¤@°_ºÎıªº¦Û³¬¯g«Ä¤l·|¬Û«H³o¬O¥Lªº¤JºÎ¤è¦¡¡C¦pªG¤÷¥À¦b«Ä¤l¤JºÎ«eÂ÷¶}, ¥L´N·|¥Î¦U¼Ë°ÝÃD¦æ¬°©Î¦Û¶Ë§Üijª½¨ì¥À¿Ë¦^¨Ó¡A¦]¬°¥À¿Ëªø´Á¦a´£¨Ñ¦Û¤v¦¨¬°ºÎ¯v»{ª¾ªº "Ápµ²"¡A¤@¥¹¦Û³¬¯g«Ä¤l­Ì¬Û«H³o¬O¥L­Ì±q¬O¿ôªº¨ìºÎµÛªºÀô¹Ò¡A¬O«ÜÃø¥Î«¡ÄU©Î¬¡°Ê´N¯à§ïÅܪº¡C¤×¨ä¦Û³¬¯g«Ä¤l¯S§O»Ý­n¨Ì¿à¤_¥L­ÌªºÀô¹Ò¬O没¦³§ïÅܪº¤~¯à¤JºÎ¡A¶V¦~ªø¶VÃø²æÂ÷Ápµ²¡A³Ì«á»Ý­n¨Ì¾aßÓª«¤~¯à±j­¢©Êªº³æ¿W¤JºÎ¡C¤÷¥À±`±`·Q¤£³qªº¬O¡A¿W¥ß¤JºÎªºÃöÁä¬O±Ð·|«Ä¤l¤£­n¨Ì¿à§Aªº¦s¦b¤~¯àºÎµÛ, ³o¸ò«Ä¤l¿ô¨Ó®É¦pªG§ä¤£¨ì§A¦Ó¦³µJ¼{¬O¤£¦s¦b¥ô¦óªºÃöÁp¡C°w¹ï³o¤@ÂI, ¥i¥H°õ¦æ "²Ö¶i¦¡ªº®ø¥¢(graduated extinction) "¡A³­¦ñ«Ä¤l¤@°_¶i¦æ©Ò¦³ºÎ«eªº¨Ò¦æ¬¡°Ê¤§«áÂ÷¶}, µM«á³]©w©T©wªº¶¡¹j®É¶¡ªð¦^, ¥H¨Ï«Ä¤l¥­ÀR¦aª¾¹D§A·|¦^¨Ó§¤¦b§ÉÃ䪺´È¤l¤W¡F¦A¨ì "°h¥h(fading)" ¡AºCºC¦a±q§¤¦b¾aªñ«Ä¤l§ÉÃ䪺¶ZÂ÷¡A¦b´X­Ó¬P´Áªº¹Lµ{¤¤³vº¥©Ô»·¦¨¬°²ßºD¨ì¤£»Ý­n§Aªº¦P¦b¯à¤JºÎ¡C¶¡¹j®É¶¡©M°h¥h¹Lµ{ªºÃöÁä¬O§ä¨ì¤@ºØ¹ï§A©M§Aªº«Ä¤l¨Ó»¡³Ì¤¬«Hªº¤èªk¡C

¡§§Úªº«Ä¤l±ß¤W¸g±`·|¿ô¨Ó¡C¡¨

ºÎ¯vªº»{ª¾Ápµ²¤]¬O©]¶¡·|±`¿ôªº¤@­ÓÃöÁ䪺­ì¦]¡C ©Ò¦³ªº«Ä¤l³£´¿¦b©]¸Ì¬ðµM¿ô¨Ó¡A³o¬OºÎ¯vªº¥¿±`³¡¤À¡CµM¦Ó¦³ºÎ¯vªº»{ª¾Ápµ²ªº«Ä¤l­Ì¿ô¨Ó·|´M§ä¥L­Ìªº "Ápµ²" ¡C¦p¤W­z¡A¤@¥¹«Ä¤l­Ìªø´Á²ßºD¤_»P¤÷¥À¤@°_¤JºÎ, ¤À©Ðªº¥L­Ì·|´M§ä¤÷¥À¡C¦pªG¤÷¥À±Ð¥L­Ì¨Ï¥Î iPad À°§U¤JºÎ, ¥L­Ì·|§äiPad¨Ã­n¨D§A¶}¾÷¡C¤@¯ë¨S¦³³o¨Ç"Ápµ²" ªº«Ä¤l­Ì¥b©]¿ô¨Ó«á¡A¬O¯à°÷½½¨­´N­«·s¦^¨ì¹Ú¶m¡C©Ò¥H´î¤Ö«Ä¤l¹ï¤÷¥À¤JºÎªº¨Ì¿à¡A´N¬O§U©ó«Ä¤l±ß¤WºÎ±o§óªøªºµª®×¡C

¨ä¹ê¤÷¥À¬O¥i¥H¬°«Ä¤l²K¥[¿n·¥ªº(¥¿­±ªº)ºÎ¯vÁpµ²¡C¨Ò¦p, ¦³¨Ç«Ä¤l±ß¤WºÎı®É, ·|¨É¨ü¹çÀRªº©]¿O¡A³oºØ¸Ë¸m¹ï¤@¨Ç¦³·P©x¿é¤Jªº¦Û³¬¯g¨àµ£¨Ó»¡¡A¬O¥i¥HÀH®É¦b®È¦æ®Éüña¨ÃÀ°§U¥L­ÌÂí©w¤U¨Ó¡C¦P¼Ë, ³ßÅw¬Y­Óªº¶ñ¥R°Êª«©Î²ßºD¥Îªº¤p´à¤l¤]¯q¤_«Ä¤l­Ì§K©óÀô¹Ò¥¢±±ªºµJ¼{¡A¤×¨ä³o¨Ç"Ápµ²" ¬O¥i¥H¾ã­Ó±ß¤W»P«Ä¤l§b¦b¤@°_ªº¡A¹ê¥Î¤W¥i¥H¨¾¤î«Ä¤lªø®É¶¡ªº©]¿ô¡C

¡§§Úªº«Ä¤l¿ô±o¤Ó¦­¤F¡C¡¨



³o¬O³Ì¨ã¬D¾Ô©Êªº¦æ¬°°ÝÃD¤§¤@¡F²Ä¤@­Ó¬D¾Ô¬O«Ä¤l¦b¿ô¨Ó®Éªº¦æ¬°©M±¡ºü¡C¦pªG«Ä¤l¬O§¹¥þ²M¿ôªº¡A¨Ã¥B¤@¾ã¤Ñªº¥\¯àªí²{¨}¦n, ¥i¯à¬O³o«Ä¤l¥u¬O»Ý­n´î¤Ö¤÷¥À©Ò­p¹ºªººÎı®É¶¡, ¤]´N¬OµL½×§A¸Õ¤F¤°»ò¤£¦Pªº¤èªk¡A¥L¥i¯à´N¬O¤£»Ý­n³o»ò¦hªººÎ¯v¡C ¦b³oºØ±¡ªp¤U, ¦pªG¦Û³¬¯g«Ä¤l¿ô¨Óªº®É¶¡¹ï¨ä¥L®a®x¦¨­û¨Ó»¡¤Ó¦­¤F, «Ä¤l¦b©Ð¶¡¸Ì¦³¦w¥þªºª±¨ã¡B¥B¦³ªx¤Æªº¿W¥ßª±­A¯à¤O, ¨º»ò§Ú«Øij§A¹w³Æµøı´£¥Ü¹Ïªí¡A­Y¦Û³¬¯g«Ä¤lÂ÷¶}¤F¦Û¤vªº©Ð¶¡¡A¨ÌµM¯à¿W¥ß¨Ì´`µøı´£¥Ü¶i¦æ¦Û®Æ¡C¦Û³¬¯g«Ä¤l­Y¯à¼ô±x­p®É¾¹¤Wªº«ü¥Ü¡A©MŪ¹q¤l®ÉÄÁªº¼Æ¦r³q±`¬O¯àª¾¹D¦ó®É¦X©yÂ÷¶}©Ð¶¡¡C«Ä¤l­Ì­Y¤£¬Oªø´Á³Q°V½m"Ápµ²"¤_­n¦³¤H³­ª±¡A¥¿½Tªº¿W¥ßª±­A¤º®e¬O¥i¥H±Ð¦Û³¬¯g«Ä¤l¦b¦Û¤vªº©Ð¶¡¸Ìª±­A, ¤@¥¹¹q¤l®ÉÄÁªº¼Æ¦r¨ì«ü©w¼Æ¥Ø´N¥i¥HÂ÷¶}¡C©ÎªÌ, §A¤]¥i¥H¦b¨C¤ÑÂǦ¹¥Îµøı´£¥Ü¹Ïªí°V½m«Ä¤l¿ô¨Óªº®É­Ô¡A¯à¿W¥ß®Þ²z«á¶i¦æ¦­¦Û²ßªº¦wÀR¾\Ū¡A³o¤]§ó¦³§Q©ó¥¼¨Ó¾Ç®Õ¥Í¬¡ªº±Æµ{¡C

¦pªG§A¤w¸g°µ¤F¤@¤ÁÃö©óºÎ¯v½Ã¥Í¡B©M°V½m§Aªº«Ä¤l¿W¥ß¤JºÎ, ¦ýºÎ¯v¬D¾Ô¨ÌµM¬O¤@­Ó¥D­nªº¥Í¬¡°ÝÃD, §A¥i¯à»Ý­n»P§Aªº¨à¬ìÂå¥Í¸ß°Ý¥H´M¨D§ó¦hªº«Øij¡A¨Ò¦p¾A¶q¥B¤£©ö¤W瘾ªºÃĪ«¡C§A¤]¥i¯à»Ý­n¸ê¸ßºÎ¯v±M®a¡C¤d¸U¤£­n»´©öÅý¥®ÄÖªº«Ä¤lªA¥Î¥«³õ¤W¦UºØ¦U¼Ëªº¸É¥R¾¯©MÃĪ« (¦p¿Æ¶Â¿E¯À),Á`¬O­n­º¥ý»P±zªº®a®xÂå¥Í¥æ½Í¡C

¾\Ū¤åÄm¨Ó·½:
Trickett, J., Heald, M., Oliver, C., & Richards, C. (2018, March 01). A cross-syndrome cohort comparison of sleep disturbance in children with Smith-Magenis syndrome, Angelman syndrome, autism spectrum disorder and tuberous sclerosis complex. Retrieved February 2018, from https://jneurodevdisorders.biomedcentral.com/articles/10.1186/s11689-018-9226-0

Helping Your Child with Autism Sleep: from http://www.royalsurrey.nhs.uk/wp-content/uploads/2015/09/Sleep-and-autism.pdf

https://www.pdasociety.org.uk/forum#/discussion/6057/useful-autism-sleep-advice-and-charities-




§Ú»{ÃѦ۳¬¯g¦]§Ú¦³¤@­Ó¦Û³¬¨à,Ä@¤À¨ÉAutism in Chinese,½Ķ³Ì·s¦Û³¬¯g¸ê°T,¨Ã¨£µý§Ú¨à¦p¦ó±oÂåªv,§â¬ü°ê²{¦æ»y¨¥¡B¦æ¬°©MªÏÅéªvÀøªº¤èªk¶Ç±Ðµ¹»Ý­nªº¦Û³¬¨à.
¬ÛÃö°T®§

¦Û³¬¯g®aªø½Ðª`·N¡G´¼¤O¯Ê¥F¬O¦]没³Q°V½m¦Û«ß ¥¿±`ªº«Ä¤l¤]¤@¼Ë¡I 

¾Ç¥Í¯Ê¥F´¼¤O¼ç¯àªº¤@­ÓÃöÁä­ì¦]:
¬O¥L­Ì没¦³³Q°V½m¾Ç²ß¦Û«ß¡I


°ª¥\¯à¦Û³¬¯g¶EÂ_ªº»~¾É¶Ë®` 
¡§°ª¥\¯à¡¨¬O¤@­Ó¤£­ã½Tªº³N»y¡A¬O°ò©óµ£¦~ªº´¼°Óµû¦ô,¦Ó¤£¬O¥\¯àµû¦ô

¦Û³¬¯g©Mµo¨|¿ð½wªº¨àµ£, ¦³ªÎ­D¯gªº°ª­·ÀI 
¦Û³¬¯g¨àµ£¤ñ¤@¯ë¦PÄ֨ൣ¦³ªÎ­D¯gªº¾÷²v°ª¥X57%!

Son-Rise¡G¬Oªv¡¦Û³¬¯gªº¯«©_¤èªkÁÙ¬O»·¥jªº©¿±y¶Ç»¡? 
­C¾|¤j¾Çªº¦Û³¬¯g±M®×¥D¥ô,Fred Volkmar«ü¥X,
Son-Rise´N¹³¶R±m²¼,¥Ã»·¦³¤H»¡,¬Y¤H¤¤¼ú¤F¡A
¦ý¨º­Ó¤H,¥Ã»·¤£¬O¦Û¤v¡C


DSM5¦Û³¬¯gÀWÃÐ(ASD)¡B¦n°Ê¯g(ADHD) »P·s¶µ¥ØªÀ¥æ[°È¹ê]·¾³q»Ùꪺ¶EÂ_¼Ð·Ç²Ó¥Ø 
§Úªº«Ä¤l¦³¦Û³¬¯g¡A¦n°Ê¯g¡BªÀ¥æ·¾³q»Ùê¬O¥²µM­Ý¦³ªº¶EÂ_¶Ü¡H

¶W¶Vªí­±ªº¶¼­¹°ÝÃD¡A1999-2014¦~¬ì¬ã±´°Q¦Û³¬¯g¨àµ£ªº­G¸z¹D¯gª¬©MªÎ­D¯g 
¬Ý¤£¨£°ÝÃD¬O³Ì¤jªº°ÝÃD¡I

2018¦~¤@¶µ­º¦¸¦b¥þ¬ü°ê¶i¦æªvÀø¦Û³¬¯gªº·sÃÄ´ú¸Õ±M®× 
Balovaptan(RG7314), 2018¦~1¤ëÀò±o¤F¬ü°ê­¹«~©MÃĪ«ºÞ²z§½(FDA) ±Â¤©ªvÀø¦Û³¬¯g(ASD)ªº¡u¬ð¯}©ÊÃĪ«¸ê®æ»{©w¡v

¦Û³¬¯g¨àµ£ºÎ¯v°ÝÃDªº¬ã¨s±M®×©M¨ó§U«Øij 
¦h¹F80% ªº¦Û³¬¯g¨àµ£¦³¬YºØµ{«×ªººÎ¯v§xÃø¡I

¦Û³¬¯g¼Ò«¬¹êÅ繫¥i¥H®M¥Î¦b¤HÃþªº¦Û³¬¯g±wªÌ¨­¤W¶Ü? 
·Q±q¦Ñ¹«¨­¤W±o¨ì¦Û³¬¯gªÀ¥æ»Ùꪺµ²½×, ¥L­Ì¥i¯à»Ý­n¦^¨ì°ò¦¥h¦³±ø¤£¯¿¦a½s¦C¦Ñ¹«©Ò¦³ªº¦æ¬°¡Cby Valerie Bolivar PhD

¦Ñ¹«ªº¬ã¨sªí©ú¥¥´Áªº·P¬V¼vÅTÀ¦¨àªº¯«¸gµo¨|,¥]¬A¦Û³¬¯g¡C 



¯}¤Ñ¯î·Ç½T¦a¹w´úÀ¦¨à¦³¦Û³¬¯gªº³Ì·s¤èªk 
¸Óºtºâªk³Ì²×¥¿½T¹w´ú¦Û³¬¯g¶EÂ_ªº¨àµ£¡A
¹F¨ì
81% ªººë½T«×©M 88%ªºÆF±Ó©Ê¡C


¸gÆ`ºÏ¨ë¿E§Þ³N(TMS)¦b¦Û³¬¯gªº¬ì¬ãÀ³¥Î 
¥Ø«e,TMSªºÁ{§É¸ÕÅçÁÙ¦b¶i¦æ,
¥D­n¬O°w¹ï¦¨¦~©ÎªÌ«C¤Ö¦~¦Û³¬¯gÃШt±wªÌ¡C
¦ý¬O
,TMSªºµ²ªG³£¬Oªì¯Åªºµ²½×¡C


§Q§¿¾¯ªvÀø¦Û³¬¯g-2017¦~ªº§ó·sµo²{ 
ÂǥѦ۳¬¯g¨àµ£µû©w¶qªí(CARS) ¡A
ºî¦XªºÁ{§É·N¨£§ïµ½¶qªí (CGI-I)¡A
©MªÀ¥æ¦^À³¶qªí (SRS) ¡A
§Q§¿¾¯(Bumetanide) ªvÀø¦³®Ä¦a§ïµ½
¤p¨à¦~ÄÖªºASD ¬ÛÃöªº¯gª¬µ{«×¡C


2012-2014 ¥ª¥kºD¥Î¤âªº°ê»Ú¬ì¬ã¸ê®Æ -´L­«¦Û³¬¯g¨àµ£¨Ï¥Î¥ª¤âªº¤¤¼Ï¯«¸g¨t²Î°¼ªº¤Ï®g 
¥ª¤â¡H¥k¤â¡H¥k¸£¡H¥ª¸£¡H

¤£­n»´©ö¬Û«H¨Ó¦Û±M·~¨ø³dªºÁÀ¨¥¡G¦Û³¬¯g¨àµ£¤£À´¬O¦]¾Ç²ß¿ð½w¡I 
¤÷¥Àªü¡A¬°¤F§A¦Û¤vÁÙ¦³«Ä¤l¤@¥Íªº¦n³B¡A§A¤£¥i¤£ª¾¡B¤]¤£¥iµLª¾¥¿½Tªº¬ì¾ÇÃÒ¾Ú¡G
¬ü°êªºCDC©x¤è¤_2016 ¦~¤½吿¬ì¾ÇÃÒ¾Ú¡A
¡u´X¥G46%¦Û³¬¯g«Ä¤l¦³¥­§¡©Î°ª©ó´¼°Ó85¡v¡C
¾Ç²ß¿ð½w°Z¬O¯u²z¡H


¨ä¥L¤å³¹¦³Ãö"¦Û³¬¯g"

¶ý«}, ©p·|¤£·|¤£­n§Ú? 
»{ª¾³sµ²ªº¬G¨Æ

³æ­¸ 
¬O½Ö°µ¤F³o¥i¬Èªº¤j¨Æ!

¤°»ò¬O¦Û³¬¯g 
©Ò¦³ªº¦Û³¬¨à³£¦³¥H¤U¬Û¦Pªº¯S¼x

¦Û³¬¨àªº­¹ª«¹L±Ó 

­È±o­«µøªº¬O,³o¨Ç«Ä¤lªº¹L±Ó¤ÏÀ³,¦b¥Ö½§ªº¥~ªí¤W¬Ý¤£¥X¨Ó!!



¦Û³¬¯g¥Í©R¥æÅT¦±¡ã§Ç¦± 
±d¨àªº¦Û³¬¯g¬O©G¶A©Î¬O¯¬ºÖ, ¨ú¨M©ó§Ú­Ì°µ¤÷¥Àªº¤ÏÀ³!

DTT¦Û³¬¯g±Ð¨|°w¹ï¤ß´¼18-24­Ó¤ë¥®¨àªººë²Ó¦Ù¦×½m²ß(1): ¥Ñ¤W©¹¤Uµe½u±ø 
 

¸U¨Æ°_ÀYªºDTT¦Û³¬¯g±Ð¨|¶}ºÝ 
DTT¦Û³¬¯g±Ð¨|¬O¥Ñ¥X¥Í®¿«Âªº®¿º¿´µ³Õ¤h(Dr.Ivar Lovaas)©Òµo©ú!

¦Û³¬¯g¨¤¸¨¤@¿h´H¥V¤¤ªº¬K·x 
 

DTT¦Û³¬¯g±Ð¨|°w¹ï¤ß´¼18-24­Ó¤ë¥®¨àªººë²Ó¦Ù¦×½m²ß (2): ¬ï¯]¤l 
 

DTT¦Û³¬¯g±Ð¨|°w¹ï¤ß´¼18-24­Ó¤ë¥®¨àªººë²Ó¦Ù¦×½m²ß (3): ¾Ç²ß¹ïºP 
 

¥»¥Ø¿ý¤¤³Ì¦h¾\Äýªº¤å³¹

¦Û³¬¨àªº­¹ª«¹L±Ó 

­È±o­«µøªº¬O,³o¨Ç«Ä¤lªº¹L±Ó¤ÏÀ³,¦b¥Ö½§ªº¥~ªí¤W¬Ý¤£¥X¨Ó!!



°£¨E¤¤¬rªº²{¦æ¤èªk 
¦pªG¦Û³¬¨à³Q´ú¥X¦³­«ª÷Äݤ¤¬r,¦b¬ü°ê³\¦hªºÂå¥Í¶}©l¨Ï¥ÎDMSA

Âå¥Í¯à¬°¦Û³¬¨à°µ¤°»ò? (1) 
¤@¦ì¹ïªºÂå¥Í¯à¦b¦Û³¬¨àªº¨­¤W¶}±Ò³\¦h©_§®ÂàÅܪº§@¬°!

¤°»ò¬O¦Û³¬¯g 
©Ò¦³ªº¦Û³¬¨à³£¦³¥H¤U¬Û¦Pªº¯S¼x

ºû¥L©Rªº§U¯q 
¯S®í¨àµ£ªº¯S®í¶¼­¹!

Í¢ªº¶q±a³q¹M¤Ñ¤U¡AÍ¢ªº¨¥»y¶Ç¨ì¦a·¥¡C¡]¸Ö 19:4¡^    Email: info@w4j.org    Powered by Web4Jesus (W4J) Ministry